Epilepsy with Myoclonic atonic Seizures (EMAtS)
SPECIAL INTEREST GROUP
We aim to further elucidate the natural history of EMAtS, investigate the current diagnostic and therapeutic milieu, and move toward discovering, evaluating, and implementing the optimal treatments for this disease. This involves developing a comprehensive prospective registry to eventually identify biomarkers for treatment outcomes and also to establish best practices in the care of this epilepsy as well as develop and implement comparative trials of appropriate therapies.
Our group meets on the fourth Tuesday of the month at 5:15 pm EST
Sig leader
Susan Fong, MD, PhD
Cincinnati Children's Hospital
-
Dr. Susan Fong is a Pediatric Epileptologist at Cincinnati Children's Hospital Medical Center where she serves as the Director of the Ketogenic Dietary Therapy Program. She completed her pediatric residency at Cincinnati Children’s Hospital followed by child neurology residency and epilepsy fellowship at Johns Hopkins. She has a PhD in Neuroscience and research background in functional MRI and autism.
Her focus is on advancing care for pediatric epilepsy patients and their caregivers. Her clinical work includes epilepsy diagnosis, electroencephalography, and seizure management using a multi-faceted approach to patient care including medication, epilepsy surgery, dietary therapy, and access to appropriate clinical trial opportunities.
Her current academic passion is in novel therapeutics for developmental and epilepsy encephalopathies, including clinical trials for gene-based therapies. She has been an active member of PERC since 2022. She is the leader for the EMAtS (epilepsy with myoclonic-atonic seizures) SIG and serves as a member of the Partnership, Membership/Nominating, and Research Committees.